Your browser doesn't support javascript.
loading
Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas.
Hepner, Adriana; Porter, Jason; Hare, Felicia; Nasir, Syed Sameer; Zetterberg, Henrik; Blennow, Kaj; Martin, Michael Gary.
Affiliation
  • Hepner A; Medical Oncology Service, Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Porter J; Division of Hematology and Oncology, University of Tennessee Health Science Center/West Cancer Center, Memphis, TN, USA.
  • Hare F; Division of Hematology and Oncology, University of Tennessee Health Science Center/West Cancer Center, Memphis, TN, USA.
  • Nasir SS; Division of Hematology and Oncology, University of Tennessee Health Science Center/West Cancer Center, Memphis, TN, USA.
  • Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Molndal, Sweden.
  • Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden.
  • Martin MG; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
World J Oncol ; 10(4-5): 169-175, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31636790
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: World J Oncol Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Risk_factors_studies Language: En Journal: World J Oncol Year: 2019 Document type: Article Affiliation country: Country of publication: